UnitedHealthcare CEO Brian Thompson was one of several senior executives at the company under investigation by the Department of Justice when he was gunned down outside a Manhattan hotel on Wednesday.
Thompson — who was killed in what police called a targeted shooting outside the Hilton hotel in Midtown — exercised stock options and sold shares worth $15.1 million on Feb. 16, less than two weeks before news of the federal antitrust probe went public, according to a Crain’s New York Business report from April.
The stock price dropped sharply after the revelation that the DOJ was investigating whether the company had made acquisitions that consolidated its market position in violation of antitrust laws, a source familiar with the probe told the outlet.
Thompson’s stock options reportedly had several years until expiration, and the sale of shares was his first since assuming the helm of parent company UnitedHealth’s insurance division in 2021.
Thompson, 50, along with UnitedHealth Group chairman Stephen Helmsley, Chief People Officer Erin McSweeney and Chief Accounting Officer Tom Roos, sold a combined $101.5 million in shares, with Helmsley personally netting just shy of $85 million, according to the report. […]
— Read More: nypost.com
